New cancer drug shows promise in early trial for advanced tumors
Disease control
Terminated
This early-phase study tested a new drug called PHN-010 in 26 people with advanced solid tumors (lung, colon, endometrial, ovarian, or cervical cancer) that had already been treated with at least one prior therapy. The drug is an antibody-drug conjugate designed to deliver a toxi…
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:39 UTC